SS Innovations International, Inc.
SSII Healthcare Medical Devices
SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024. In the quarter to June 2026, revenue grew 39.4%, EPS fell 669.2%, free cash flow fell 16.6% and total debt rose 109.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SSII
SS Innovations International, Inc. (SSII) P/E ratio
SS Innovations International, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 10 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MASS 908 Devices Inc. compare | n/m |
| SGHT Sight Sciences, Inc. compare | n/m |
| PACB Pacific Biosciences of California, Inc. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| SSII SS Innovations International, Inc. | n/m |
| KIDS OrthoPediatrics Corp. compare | n/m |
| TCMD Tactile Systems Technology, Inc. compare | 20.5× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 24.8× |
| DCTH Delcath Systems, Inc. compare | 1,408× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)